1.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised...
by Serruys, Patrick W, Prof
The Lancet (British edition), 2016, Vol.388 (10059), p.2479-2491
2.
Polymer‐free versus permanent polymer‐coated drug eluting stents for the treatment of coronary artery disease: A meta‐analysis of randomized trials
by Nogic, Jason
Journal of interventional cardiology, 2018, Vol.31 (5), p.608-616
3.
Impact of stent diameter and length on in‐stent restenosis after DES vs BMS implantation in patients needing large coronary stents—A clinical and health‐economic evaluation
by Zbinden, Rainer
Cardiovascular therapeutics, 2017, Vol.35 (1), p.19-25
5.
Drug eluting stents: an updated meta-analysis of randomised controlled trials
by Roiron, C
Heart (British Cardiac Society), 2006, Vol.92 (5), p.641-649
6.
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
by Palmerini, Tullio, MD
The Lancet (British edition), 2012, Vol.379 (9824), p.1393-1402
7.
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
by Serruys, Patrick W, Prof
The Lancet (British edition), 2009, Vol.373 (9667), p.897-910
8.
Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised tr...
by Palmerini, Tullio, MD
The Lancet (British edition), 2015, Vol.385 (9985), p.2371-2382
9.
Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography
by Cassese, Salvatore
Heart (British Cardiac Society), 2014, Vol.100 (2), p.153-159
10.
110 Noninferiority of a Direct Aspiration First-Pass Technique vs Stent Retriever Thrombectomy in Emergent Large-Vessel Intracranial Occlusions
by Stapleton, Christopher J
Neurosurgery, 2016, Vol.63 (CN_suppl_1), p.146-147
11.
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled t...
by Ali, Ziad A, MD
The Lancet (British edition), 2016, Vol.388 (10060), p.2618-2628
12.
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferior...
by Mäkikallio, Timo, MD
The Lancet (British edition), 2016, Vol.388 (10061), p.2743-2752
13.
Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial
by Kelbæk, Henning, Dr
The Lancet (British edition), 2016, Vol.387 (10034), p.2199-2206
14.
Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multi...
by Maeng, Michael, Dr
The Lancet (British edition), 2014, Vol.383 (9934), p.2047-2056
15.
Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
by Wang, Xiao-Zeng
Chinese medical journal, 2015, Vol.128 (6), p.721-726
17.
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an...
by Serruys, Patrick W, Prof
The Lancet (British edition), 2015, Vol.385 (9962), p.43-54
18.
Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT...
by Christiansen, Evald Høj, Dr
The Lancet (British edition), 2013, Vol.381 (9867), p.661-669
19.
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospect...
by Haude, Michael, Prof
The Lancet (British edition), 2016, Vol.387 (10013), p.31-39
20.
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (...
by Raungaard, Bent, Dr
The Lancet (British edition), 2015, Vol.385 (9977), p.1527-1535
